Machado D, Pereira C, Teixeira L, Canelas A, Tavares B, Loureiro G, Calado G, Ribeiro C, Chieira C
Immunoallergy Department, Coimbra University Hospital, Coimbra, Portugal.
Eur Ann Allergy Clin Immunol. 2009 Oct;41(5):139-45.
High-resolution computed tomography (HRCT) is a widespread medical imaging method for the study of thoracic diseases. In asthma it is very useful particularly when it is difficult to achieve an effective control of disease, and in severe deterioration.
It was intended to evaluate the imaging changes by HRCT in asthmatic patients and to assess the expression according to the symptoms and duration of disease.
Thirty three patients from the Outpatient Department, with asthma classified in the different clinical severity stages according to GINA, were randomly included. They were submitted to HRCT (Somaton Plus-4, Siemens). The lesions were classified in reversible (mucoid impaction, acinar pattern centrilobular nodules and lobar collapse) and irreversible (bronchiectasis, bronchial wall-thickening, sequellar line shadows and emphysema).
The 33 asthmatic patients (20 female) had an average age of 44.76 +/- 16.98 years and a mean disease evolution time of 23.39 +/-14.83 years. 30% had mild persistent asthma, 43% moderate persistent asthma and 27% severe persistent asthma. All the patients were under inhaled corticotherapy. Only 6 patients had normal HRCT 4 with mild persistent asthma (4 to 25 years of duration of disease) and 2 with moderate persistent (10 to 48 years of duration of disease). 81.81% of the patients had changes in HRCT, being the irreversible lesions the most frequent. The most important irreversible lesions were observed in severe asthma patients with longer duration of disease. All the patients with reversible lesions had also irreversible changes. Most of the bronchiectasis were centrally located and were found in severe asthma patients. Irreversible changes were identified in 3 patients with mild asthma and a maximum of 6 years of duration of disease.
HRCT findings were related with asthma severity and long lasting disease but there are some asthmatics that also present early abnormalities, even in milder forms. All the groups of asthmatic patients presented all types of imaging changes, including the irreversible ones. In asthma these changes can be the result of individual patterns of response to frequent exacerbations, leading to a persistent chronic inflammatory process that will determine airway remodelling, even in early stages of disease and/or mild asthma.
高分辨率计算机断层扫描(HRCT)是一种广泛应用于胸部疾病研究的医学成像方法。在哮喘中,它非常有用,特别是在难以有效控制疾病以及病情严重恶化时。
旨在评估哮喘患者HRCT的影像学变化,并根据症状和病程评估其表现。
随机纳入门诊33例根据全球哮喘防治创议(GINA)分类为不同临床严重程度阶段的哮喘患者。对他们进行HRCT检查(西门子Somaton Plus-4)。病变分为可逆性(黏液嵌塞、腺泡样中心小叶结节和肺叶萎陷)和不可逆性(支气管扩张、支气管壁增厚、条索状阴影和肺气肿)。
33例哮喘患者(20例女性)平均年龄为44.76±16.98岁,平均病程为23.39±14.83年。30%为轻度持续性哮喘,43%为中度持续性哮喘,27%为重度持续性哮喘。所有患者均接受吸入性皮质激素治疗。只有6例轻度持续性哮喘(病程4至25年)和2例中度持续性哮喘(病程10至48年)患者的HRCT正常。81.81%的患者HRCT有改变,其中不可逆性病变最为常见。在病程较长的重度哮喘患者中观察到最重要的不可逆性病变。所有有可逆性病变的患者也有不可逆性改变。大多数支气管扩张位于中央,见于重度哮喘患者。3例轻度哮喘且病程最长6年的患者出现了不可逆性改变。
HRCT表现与哮喘严重程度和病程长短有关,但也有一些哮喘患者即使病情较轻也会出现早期异常。所有哮喘患者组均出现了各种类型的影像学改变,包括不可逆性改变。在哮喘中,这些改变可能是对频繁发作的个体反应模式的结果,导致持续的慢性炎症过程,即使在疾病早期和/或轻度哮喘阶段也会决定气道重塑。